Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Combination with Metformin

被引：0
|
作者：
Andrea D. Fass
Jennifer A. Gershman
机构：
[1] Nova Southeastern University,Department of Pharmacy Practice
[2] College of Pharmacy,undefined
来源：
Advances in Therapy | 2013年 / 30卷
关键词：
Alogliptin; Combination therapy; Dipeptidyl peptidase-4 inhibitors; Linagliptin; Metformin; Saxagliptin; Sitagliptin; Type 2 diabetes; Vildagliptin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：337 / 353
页数：16
相关论文
共 50 条
  • [41] Comparative Clinical Pharmacokinetics of Dipeptidyl Peptidase-4 Inhibitors
    Golightly, Larry K.
    Drayna, Caitlin C.
    McDermott, Michael T.
    CLINICAL PHARMACOKINETICS, 2012, 51 (08) : 501 - 514
  • [42] The effects of dipeptidyl peptidase-4 inhibitors on kidney outcomes
    O'Hara, Daniel V.
    Parkhill, Thomas R.
    Badve, Sunil V.
    Jun, Min
    Jardine, Meg J.
    Perkovic, Vlado
    DIABETES OBESITY & METABOLISM, 2021, 23 (03): : 763 - 773
  • [43] Dipeptidyl Peptidase-4 Inhibitors and Their Effects on the Cardiovascular System
    Solun, B.
    Marcoviciu, D.
    Dicker, D.
    CURRENT CARDIOLOGY REPORTS, 2013, 15 (08)
  • [44] Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Outcome
    Kim, Kwang-il
    KOREAN CIRCULATION JOURNAL, 2018, 48 (05) : 430 - 432
  • [45] Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas
    Deacon, C. F.
    Lebovitz, H. E.
    DIABETES OBESITY & METABOLISM, 2016, 18 (04): : 333 - 347
  • [46] Dipeptidyl peptidase-4 inhibitors as new tools for cardioprotection
    Marina Rankovic
    Nevena Jeremic
    Ivan Srejovic
    Katarina Radonjic
    Aleksandra Stojanovic
    Milos Glisic
    Stefani Bolevich
    Sergey Bolevich
    Vladimir Jakovljevic
    Heart Failure Reviews, 2021, 26 : 437 - 450
  • [47] Dipeptidyl Peptidase-4 Inhibitors and Their Effects on the Cardiovascular System
    B. Solun
    D. Marcoviciu
    D. Dicker
    Current Cardiology Reports, 2013, 15
  • [48] A META-ANALYSIS OF EFFICACY AND SAFETY OF DIPEPTIDYL PEPTIDASE-4 [DPP-4] INHIBITORS IN TYPE 2 DIABETES
    Park, H.
    Park, C.
    Kim, Y.
    Rascati, K. L.
    VALUE IN HEALTH, 2012, 15 (04) : A172 - A172
  • [49] Dipeptidyl peptidase-4 inhibitors increase risk of IBD
    Reactions Weekly, 2018, 1696 (1) : 5 - 5
  • [50] Dipeptidyl Peptidase-4 Inhibitors: 3 Years of Experience
    Derosa, Giuseppe
    Maffioli, Pamela
    DIABETES TECHNOLOGY & THERAPEUTICS, 2012, 14 (04) : 350 - 364
12345